Powered by

BioPharma Services awarded WHO's stamp of approval to support pharmaceutical companies in treating HIV/AIDS, TB and malaria

Nov 20, 2018 - Global Banking News

BioPharma Services Inc (BioPharma) revealed on Monday that it has successful passed World Health Organization (WHO) GCP/GLP/BE assessment and review of its Toronto, Canada site.

The company's Toronto, Canada site was found to be in compliance with WHO Good Clinical Practice Guidance for in vivo bioequivalence studies valid through to the 1st of January 2021.

This assessment is one of the first steps in the prequalification process when submitting a finished pharmaceutical product (F...